| Literature DB >> 32180723 |
James R Groome1, Landon Bayless-Edwards1,2.
Abstract
Voltage-gated ion channels share a common structure typified by peripheral, voltage sensor domains. Their S4 segments respond to alteration in membrane potential with translocation coupled to ion permeation through a central pore domain. The mechanisms of gating in these channels have been intensely studied using pioneering methods such as measurement of charge displacement across a membrane, sequencing of genes coding for voltage-gated ion channels, and the development of all-atom molecular dynamics simulations using structural information from prokaryotic and eukaryotic channel proteins. One aspect of this work has been the description of the role of conserved negative countercharges in S1, S2, and S3 transmembrane segments to promote sequential salt-bridge formation with positively charged residues in S4 segments. These interactions facilitate S4 translocation through the lipid bilayer. In this review, we describe functional and computational work investigating the role of these countercharges in S4 translocation, voltage sensor domain hydration, and in diseases resulting from countercharge mutations.Entities:
Keywords: channelopathy; countercharge; crystallography; electrostatic; ion channel; molecular dynamics; sliding helix model; voltage sensor domain
Year: 2020 PMID: 32180723 PMCID: PMC7059764 DOI: 10.3389/fphar.2020.00160
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
Figure 1Multiple sequence alignments of voltage sensor domains (VSDs) (S1–S4) from a sample of voltage-gated ion channel (VGIC) alpha subunit domains. Prokaryotic sodium channels are NaVAb from Arcobacter butzleri (Payandeh et al., 2011), and the NaChBac orthologue NaVRh from alpha proteobacterium (Zhang et al., 2012). The remaining sequences are human. For each alignment, putative consensus negative charge regions are highlighted with boxes colored according to frequently observed residues (glutamate, yellow; asparagine, red; aspartate, blue). The first five positively charged residues in S4 are shown in green.
Figure 2(A) Conservation of amino acid residues in voltage sensor domains (VSDs) across taxa, highlighting the evolutionary conservation of polar or acidic residues in S1–S3 (putative countercharges), positively charged arginine or lysine residues in S4, and conserved aromatic residues. With permission from J. Gen. Physiol. and first author (Palovcak et al., 2014). (B) Homology model of hNaV1.4 domain IV VSD based on prokaryotic structural information [3RVY.pdb, (Payandeh et al., 2011)] showing locations of consensus S1–S3 countercharges in the extracellular negatively charged (ENC) and intracellular negatively charged (INC) regions. A conserved aromatic in S2 (yellow) is also shown as part of the gating charge transfer center (GCTC). (C) Top view of the VSD showing side chains of S1–S3 countercharges facing the S4 arginine guanidyl groups.
Specific countercharge/S4 residue interactions identified in potassium channels.
| Channel | Countercharge locus | S4 locus | Experimental approach | Functional interaction | Reference |
|---|---|---|---|---|---|
|
| S2 ENC (E283) | R3 (R368) | Charge swapping | Folding (maturation) |
|
| S2 INC (E293) | K5 (K374) | Charge swapping | Folding (maturation) |
| |
| S2 ENC (E283) | R3 (R368) | Charge swapping | Intermediate (deactivated) state |
| |
| S2 ENC (E283) | R1 (R362) | Double mutations, omega current | Resting state |
| |
| EAG | S2 ENC (D274) | R3 (R353) | Ni2+ inhibition | Activated state |
|
| hERG | S1 INC (D411) | K5 (K538) | Mutant cycle analysis | Intermediate (deactivated) state |
|
| S2 ENC (D456) | K1 (K525) | Mutant cycle analysis | Intermediate (deactivated) state |
|
For each channel, residues are identified in ENC (extracellular negatively charged) or INC (intracellular negatively charged) regions of S1–S3 segments, locus in S4 segment, and with interpreted role of their paired interaction.
Specific countercharge/S4 residue interactions identified in NaChBac sodium channels.
| Channel | Countercharge locus | S4 locus | Experimental approach | Functional interaction | Reference |
|---|---|---|---|---|---|
| NaChBac | S2 ENC (D60) | R3 (R119) | Cysteine substitution disulfide locking | Activated state |
|
| S2 ENC (D60) | R4 (R122) | Cysteine substitution disulfide locking | Intermediate |
| |
| S1 ENC (E43) | T0 (T110) | Cysteine substitution disulfide locking | Resting state |
| |
| S1 ENC (E43) | R2 (R116) | Cysteine substitution disulfide locking | Intermediate |
| |
| S2 ENC (D60) | T0 (T110) | Cysteine substitution | Resting state |
| |
| S1 ENC (E43) | R1 (R113) | Mutant cycle analysis | Resting state |
|
Residues are identified in extracellular negatively charged (ENC) or intracellular negatively charged (INC) regions of S1–S3 segments, locus in S4 segment, and with interpreted role of their paired interaction.
Figure 3Scanning mutagenesis of putative countercharges in domains II and IV of the skeletal muscle sodium channel NaV1.4. Charge-reversing mutations in domain II decrease activation probability (indicated by shift in V0.5), while those in domain IV slow the entry of channels into a fast-inactivated state (indicated by the ratio of time constant (tau) of mutation with respect to that of wild type, at 20 mV). These effects are consistent with the hypothesis that countercharges facilitate certain domain-specific functions highlighted by green arrows (DII activation, DIV fast inactivation). Adapted from Groome and Winston (2013). Colors indicate countercharge loci as extracellular negatively charged (ENC) (green, red), or intracellular negatively charged (INC) (blue).
Figure 4Electrostatic interactions between countercharges (aspartate, blue; glutamate, green; asparagine, purple; serine, yellow, cysteine, cyan) and each of four to five positively charged residues in S4 segments (arginine or lysine, red) in domains I–IV of the skeletal muscle sodium channel NaV1.4. Nodes indicate charged and polar residues within the voltage sensor, while edge width indicates strength of interaction. The profile of interactions is given for a presumptive resting state, intermediate closed state, and activated state. Reproduced with permission from Idaho State University Libraries (Bayless-Edwards, 2019).
Voltage-gated ion channel (VGIC) countercharge S1–S3 mutations identified in human disease phenotypes.
| Gene | S1 mutation | S2 mutation | S3 mutation | Phenotype | Reference |
|---|---|---|---|---|---|
| SCN1A | DI: N191K/Y | EIEE6 |
| ||
| DI: D194G/N | EIEE6 |
| |||
| DIII: E1221K | EIEE6 |
| |||
| DIII: S1231R/T | EIEE6 |
| |||
| DIII: E1238D | EIEE6 |
| |||
| DIII: E1266A | EIEE6 |
| |||
| DIII: D1288N | EIEE6 |
| |||
| DIV: D1544A/G | EIEE6 |
| |||
| DIV: E1561K | EIEE6 |
| |||
| DIV: N1605I/S | EIEE6 |
| |||
| DIV: D1608G/Y | EIEE6 |
| |||
| SCN2A | DI: N132K | EIEE11 |
| ||
| DI: E169G | EIEE11 |
| |||
| DIII: E1211K | EIEE11 |
| |||
| SCN4A | DIII: D1069N | CM |
| ||
| DIV: N1366S | PMC |
| |||
| SCN5A | DI: E161K/Q | BRGDA/PFHB |
| ||
| DIII: E1225K | BRGDA/LQT-3 |
| |||
| DIII: D1243N | BRGDA |
| |||
| DIII: E1253G | BRGDA |
| |||
| DIII: D1275N | BRGDA/AS/DCM |
| |||
| DIV: N1541D | BRGDA/AF/SND |
| |||
| DIV: E1548K | BRGDA |
| |||
| DIV: E1574K | BRGDA |
| |||
| DIV: D1595N/H | DCM/SND/AV Block |
| |||
| KCNQ1 | C136F | LQT-1 |
| ||
| E160K/V | LQT-1 |
| |||
| S199A | LQT-1 |
| |||
| D202H/N | LQT-1 |
| |||
| KCNH2 | T421M | LQT-2 |
| ||
| S428L | LQT-2 |
| |||
| D456Y | LQT-2 |
| |||
| D466Y | LQT-2 |
| |||
| D501H/N | LQT-2 |
| |||
| KCNA1 | N225D | HM |
|
EIEE, early infantile epileptic encephalopathy; CM, congenital myopathy; PMC, paramyotonia congenita; BRGDA, Brugada syndrome; PFHB, progressive familial heart block; LQT, long QT syndrome; AS, atrial standstill; DCM, dilated cardiomyopathy; SND, sinus node dysfunction; HM, hypomagnesemia.